Anna Albiero is an experienced consultant and senior analyst at Dolon Ltd since January 2021, specializing in market access strategies for orphan drugs and innovative medicines. Anna has a strong research background, having worked at the University of Cambridge from October 2015 to December 2020, focusing on European policies for stem cell and regenerative medicine as well as molecular cancer diagnostics. Anna earned a PhD in Biological and Biomedical Sciences from the University of Cambridge and holds a Master's in Biomedical Sciences from Leiden University and a Bachelor's in Molecular Biotechnology from Università di Trento. Additionally, Anna has participated in entrepreneurial programs at Cambridge Judge Business School and Cambridge Judge Entrepreneurship Centre, further enhancing business development skills within the pharmaceutical sector.
This person is not in any teams
This person is not in any offices